bluebird bio, Inc. (NASDAQ:BLUE) Given Consensus Recommendation of “Hold” by Analysts
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have earned a consensus recommendation of “Hold” from the eight ratings firms that are covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month target […]
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have earned a consensus recommendation of “Hold” from the eight ratings firms that are covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month target […]
